Le marché des anticorps personnalisés était évalué à 833,71 millions de dollars US en 2028, contre 409,26 millions de dollars US en 2021 ; on estime qu'il croîtra à un TCAC de 10,7 % de 2021 à 2028.
Des anticorps personnalisés peuvent être générés chez une souris, un rat ou un hamster, pour répondre à toutes les exigences de l'hôte. Les entreprises fournissent une large gamme d'anticorps en fonction des besoins du chercheur. Il existe une variété d'anticorps personnalisés sur le marché, notamment des anticorps polyclonaux et monoclonaux, des anticorps monoclonaux recombinants, des anticorps d'hybridome, des anticorps polyclonaux recombinants, etc. Les entreprises offrent des services d'assistance complets pour tous les types et étapes de production d'anticorps, de la conception, de la synthèse et de la conjugaison de protéines porteuses de peptides à l'immunisation des animaux, à la collecte de sérum ou à la fusion d'hybridomes, à l'analyse du titre et à la purification finale des anticorps.
La croissance du marché des anticorps personnalisés est attribuée à des facteurs tels que la forte demande de recherche, le soutien croissant des gouvernements, l'évolution constante des profils de maladies, l'augmentation des partenariats public-privé et l'augmentation des activités de financement améliorent largement les performances de la biotechnologie. Cependant, la production des anticorps monoclonaux et polyclonaux varie en fonction des animaux utilisés pour les dériver. Le coût est également déterminé par les packages d'anticorps personnalisés demandés pour différentes applications qui sont proposés par différents acteurs, ce qui entrave la croissance du marché.
Régions lucratives pour le marché des anticorps personnalisés
Aperçus du marché
Services de production et de développement offerts par des fournisseurs d'anticorps personnalisés
Diverses entreprises proposent activement des services de recherche et développement pour des anticorps personnalisés. Quelques-uns de ces services lancés par ces sociétés sont mentionnés ci-dessous.
- En juin 2021, GenScript a annoncé le lancement de son MonoRab, un service personnalisé d'anticorps monoclonaux de lapin (mAB). Il est ajouté au portefeuille de services d'anticorps haut de gamme intégrés de la société. MonoRab est la technologie exclusive de la société qui utilise la combinaison de technologies d'hybridome et de séquençage d'anticorps monoclonaux à un stade précoce. Les deux technologies fournissent des mAb de lapin personnalisés qui sont plus spécifiques et possèdent une affinité plus élevée ainsi que des capacités diversifiées requises pour un large éventail d'applications.
- En mars 2021, Giotto Biotech a lancé des services spécialisés de production d'anticorps polyclonaux et monoclonaux. La société facilite la production de plus de 500 types d'anticorps monoclonaux qui peuvent être utilisés pour des applications diagnostiques et thérapeutiques. Il offre un large choix d'espèces comme sources d'anticorps polyclonaux.
- En novembre 2020, l'AMSBIO a annoncé des services de développement d'anticorps monoclonaux recombinants de lapin et de souris. Le développement d'anticorps monoclonaux recombinants s'appuie sur la plateforme de développement DimAb, différente des technologies classiques de fusion d'hybridomes. Il a la capacité d'isoler les gènes IgG des cellules B des animaux immunisés. Ces anticorps aident au développement et à la commercialisation de médicaments sur le marché. En octobre 2019, la FDA a approuvé le premier médicament dérivé d'anticorps monoclonaux de lapin, Beovu. Beovu est destiné à traiter la dégénérescence maculaire liée à l'âge (DMLA) humide.
- En mars 2020, Absolute Antibody Ltd a annoncé le lancement d'un service de production d'anticorps recombinants à haut débit pour son FleXpress. La société propose à ses clients des services pour faciliter l'expression rapide de nombreux anticorps, jusqu'à un volume de 80 ml, ainsi que pour propulser la capacité de production pour répondre aux demandes croissantes de technologie d'anticorps recombinants.
Ces services de production d'anticorps personnalisés offerts par les entreprises accélèrent la croissance du marché.
Service - Based Insights
Basé sur le service, le marché des anticorps personnalisés est segmenté en développement d'anticorps, anticorps production et purification, et fragmentation et marquage des anticorps. En 2020, le segment de développement d'anticorps détenait la plus grande part du marché et devrait croître à un TCAC significatif au cours de la période de prévision.
Marché des anticorps personnalisés, par service - 2020 et 2028
< p>Insights basés sur le type
En fonction du type, le marché des anticorps personnalisés est segmenté en anticorps monoclonaux, anticorps polyclonaux et autres anticorps personnalisés. En 2020, le segment des anticorps monoclonaux détenait la plus grande part du marché, tandis que le segment des anticorps polyclonaux devrait croître au cours de la période de prévision.
Informations basées sur la source
Basé sur la source , le marché des anticorps personnalisés est segmenté en souris, lapin et autres. Le segment des souris détenait la plus grande part du marché en 2020, tandis que le segment des souris devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.
Insights basés sur le domaine de recherche
En fonction du domaine de recherche, le marché des anticorps personnalisés est segmenté en oncologie, immunologie, cellules souches, maladies infectieuses, neurobiologie, maladies cardiovasculaires et autres. Le segment de l'oncologie détenait la plus grande part du marché en 2020, tandis que le segment des cellules souches devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.
Insights basés sur les utilisateurs finaux
< p>Sur la base des utilisateurs finaux, le marché des anticorps personnalisés est segmenté en sociétés pharmaceutiques et biotechnologiques, instituts universitaires et de recherche et organismes de recherche sous contrat. En 2020, le segment des sociétés pharmaceutiques et biotechnologiques détenait la plus grande part du marché et devrait croître au rythme le plus rapide au cours des prochaines années.
Insights stratégiques
Lancements et approbations de produits sont les stratégies couramment adoptées par les entreprises pour étendre leur empreinte mondiale et leurs portefeuilles de produits. De plus, les acteurs du marché de la reconstruction mammaire se concentrent sur la stratégie de collaboration pour élargir leur clientèle, ce qui, à son tour, leur permet de maintenir leur marque à l'échelle mondiale.
Par service
- Développement d'anticorps
- Production et purification d'anticorps
- Fragmentation et marquage d'anticorps
Par type
- Anticorps monoclonaux
- Anticorps polyclonaux
- Autres anticorps personnalisés
Par source
- Souris
- Lapins
- Autres
Par domaine de recherche
- Oncologie
- Immunologie
- Cellules souches
- Maladies infectieuses
- Neurobiologie
- Maladies cardiovasculaires
- Autres
Par les utilisateurs finaux h3>
- Entreprises pharmaceutiques et biotechnologiques
- Instituts universitaires et de recherche
- Organisations de recherche sous contrat
Par géographie
- Amérique du Nord
- États-Unis
- Canada
- Mexique
- Europe
- France
- Allemagne
- Italie
- Royaume-Uni
- Espagne
- Reste de l'Europe
- Asie-Pacifique (APAC)
- Chine
- Inde
- Corée du Sud
- Japon
- Australie
- Reste de l'Asie-Pacifique
- Moyen-Orient et Afrique (MEA)
- Afrique du Sud
- Arabie saoudite
- EAU
- Reste du Moyen-Orient et Afrique
- Amérique du Sud et centrale (SCAM)< ul>
- Brésil
- Argentine
- Reste de l'Amérique du Sud et centrale
Profils des entreprises
- Thermo Fisher Scientific Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- ABCAM
- GenScript
- Rockland Immunochemicals, Inc
- ProMab
- BioLegend, Inc
- Agilent Technologies, Inc
- Technologie de signalisation cellulaire, Inc
- États-Unis
- Canada
- Mexique
- France
- Allemagne
- Italie
- Royaume-Uni
- Espagne
- Reste de l'Europe
- Chine
- Inde
- Corée du Sud
- Japon
- Australie
- Reste de l'Asie-Pacifique
- Afrique du Sud
- Arabie saoudite
- EAU
- Reste du Moyen-Orient et Afrique
- Thermo Fisher Scientific Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- ABCAM
- GenScript
- Rockland Immunochemicals, Inc
- ProMab
- BioLegend, Inc
- Agilent Technologies, Inc
- Technologie de signalisation cellulaire, Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Customized antibodies can be generated in a mouse, rat or hamster, to meet any particular host requirements. Companies are providing wide range of antibodies according to the researcher's requirements. There are variety of customized antibodies in the market which includes polyclonal and monoclonal antibody, recombinant monoclonal antibody, hybridoma antibody, polyclonal recombinant antibody and others. Companies are offering complete support services for all types and steps of antibody production from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification.
The growth of the market is attributed to some key driving factors such as the high demand in research, growing support from governments, continuously changing disease profiles, rising public–private partnerships, and increasing funding activities are widely enhancing the performance of biotechnology. For instance, In January 2021, Morphic Therapeutic, a biotechnology company, collaborated with Janssen Pharmaceutical, Inc., a part of Johnson & Johnson Private Limited, to develop novel antibodies against third integrin target proteins (a family of ubiquitous receptors. Such strategic steps are also projected to drive the market growth.
The growth of the region is attributed to factors such as rising public–private partnerships, and increasing funding activities are widely enhancing the performance of biotechnology Moreover, presence of well-developed healthcare infrastructure and government support are some of the prominent factors propelling the market growth in Asia Pacific. In addition, the Europe is expected account for the fastest growth in the custom antibody market. A high demand in research, growing support from governments, continuously changing disease profiles, rising public–private partnerships, and increasing funding activities are widely enhancing the performance of biotechnology growth of Europe custom antibody market during the forecast period.
The List of Companies - Custom Antibody Market
- Thermo Fisher Scientific Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- ABCAM
- GenScript
- Rockland Immunochemicals, Inc
- ProMab
- BioLegend, Inc
- Agilent Technologies, Inc
- Cell Signaling Technology, Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jun 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jun 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jun 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jun 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Jun 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Jun 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)